Dr Kristen Stone Mulhern, MD | |
306 S New St, Bethlehem, PA 18015 | |
(484) 526-7060 | |
(484) 526-7061 |
Full Name | Dr Kristen Stone Mulhern |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 25 Years |
Location | 306 S New St, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104824457 | NPI | - | NPPES |
CA5143 | Other | IL | MEDICARE RAILROAD |
31602433 | Other | IL | BCBS PROVIDER NUMBER |
036108170 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 036108170 (Illinois) | Secondary |
207V00000X | Obstetrics & Gynecology | MD465399 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.
BioScrip, Inc. today announced fourth quarter revenues of $341.6 million and net income of $40.7 million, or $0.99 per diluted share, which includes the reversal of the Company's deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with BioScrip's pending acquisition of Critical Homecare Solutions, Inc. and $4.3 million of incentive compensation expense relating to the Company's employee compensation program.
The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.
Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.
› Verified 3 days ago
Entity Name | St Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.
BioScrip, Inc. today announced fourth quarter revenues of $341.6 million and net income of $40.7 million, or $0.99 per diluted share, which includes the reversal of the Company's deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with BioScrip's pending acquisition of Critical Homecare Solutions, Inc. and $4.3 million of incentive compensation expense relating to the Company's employee compensation program.
The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.
Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.
› Verified 3 days ago
Entity Name | Star Community Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.
BioScrip, Inc. today announced fourth quarter revenues of $341.6 million and net income of $40.7 million, or $0.99 per diluted share, which includes the reversal of the Company's deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with BioScrip's pending acquisition of Critical Homecare Solutions, Inc. and $4.3 million of incentive compensation expense relating to the Company's employee compensation program.
The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.
Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kristen Stone Mulhern, MD 306 S New St, Bethlehem, PA 18015-1652 Ph: (484) 526-7060 | Dr Kristen Stone Mulhern, MD 306 S New St, Bethlehem, PA 18015 Ph: (484) 526-7060 |
News Archive
At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.
Researchers with UCLA's Jonsson Comprehensive Cancer Center have developed and used a high-throughput molecular screening approach that identifies and characterizes chemical compounds that can target the stem cells that are responsible for creating deadly brain tumors.
BioScrip, Inc. today announced fourth quarter revenues of $341.6 million and net income of $40.7 million, or $0.99 per diluted share, which includes the reversal of the Company's deferred tax valuation allowance of $41.1 million, expenses of $1.8 million associated with BioScrip's pending acquisition of Critical Homecare Solutions, Inc. and $4.3 million of incentive compensation expense relating to the Company's employee compensation program.
The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.
Antibiotic resistance in bottlenose dolphins shows that up to 88% of pathogenic organisms in this species is resistant to one or more antibiotics. This finding offers very useful insights into the identical phenomenon in humans. This species is termed a sentinel species, which means it reflects environmental risks to humans in advance of their occurrence in humans.
› Verified 3 days ago
Carolyn Botros, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1770 Bathgate Rd Ste 401, Bethlehem, PA 18017 Phone: 484-884-8840 Fax: 484-884-8827 | |
Dr. Emer Colalillo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 834 Eaton Ave, Bethlehem, PA 18018 Phone: 484-526-7474 | |
Sarah Jane Cathryn Muder, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-503-8217 | |
Dr. Anita Sargent, M.D., PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 325 W Broad St, 3rd Floor, Bethlehem, PA 18018 Phone: 424-626-9250 Fax: 484-626-9255 | |
Dr. Kathleen Eleanor Ackert, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4670 | |
Dr. John Roizin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 31 S Commerce Way, Bethlehem, PA 18017 Phone: 484-821-0821 Fax: 484-821-0826 | |
Dr. Melat Worku Tiruneh, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4670 Fax: 833-828-1814 |